[New possibilities in testing resistance of human carcinoma tissue to cytostatic agents in vivo].
D000818:Animals; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy*; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000627:therapeutic use; D011035:Podophyllum / Q000627:therapeutic use*; D051381:Rats; D013852:Thiotepa / Q000627:therapeutic use*; D014228:Triaziquone / Q000627:therapeutic use*
D003520:Cyclophosphamide; D011033:Podophyllin; D013852:Thiotepa; D014228:Triaziquone; D008727:Methotrexate
Neue Möglichkeiten einer Resistenzprüfung nenschlicher Karzinomgewebe gegen Zytostatika im In-vivo-Test.